ELTX Q1 2026 Earnings EPS Miss as ClinicalStage Biotech Advances Pipeline Without Revenue VVX Q1 2026 Earnings Strong EPS Beat of 475 Surprises Market ENIC Q4 2025 Earnings Earnings Beat Estimates Amid Challenging Market Conditions MSCI Q1 2026 Earnings Slight EPS Beat Amid Steady Demand for Index and Analytics Altimmune Q1 2026 Earnings Narrower Loss Surprises Amid Ongoing Clinical Focus WYNN Q1 2026 Earnings EPS Misses Estimates by 226 Stock Gains 342